TrialNeuro-oncology2010

Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial.

Benedikte Hasselbalch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.